ATS Medical, Inc.

Developer and manufacturer of products for the cardiac surgery market

Developer and manufacturer of products for the cardiac surgery market

ATS Medical, Inc. was headquartered in Minnesota, and traded on the NASDAQ under symbol ATSI. The Company developed, manufactured, and marketed medical devices for the treatment of structural heart disease. Its product portfolio included: mechanical and tissue valves, heart valve repair products, cryoablation products used in the treatment of cardiac arrhythmias, and surgical tools and accessories. Medtronic (MDT) acquired ATS Medical for $370M in 2010.

  • Minneapolis, MN

  • Contact:
    Marty Sutter
  • Acquisition
  • Acquired by: Medtronic
  • Exit date: April 29, 2010
  • Logo

“Business of course is the allocation of human and capital resources to create customers; it’s really a very simple exercise but such a hard thing to execute well in practice. Essex understands the algorithm and importantly possesses the wisdom gained from experience to know when and how to partner with its companies. Whether solving problems or capitalizing on opportunity, I have seldom worked with nicer, smarter people in my career. Their collective experience and strong strategic sense is deep and broad and available at the asking, to which we called upon regularly as we built ATS Medical!”

Michael Dale

Chairman, President and CEO

Testimonials and endorsements reflect portfolio company management’s opinions and beliefs regarding the company and the investment. Such opinions and beliefs are subjective, do not represent a complete assessment of the company, the market or EW’s overall investment performance and cannot be independently verified. Such statements are being offered as references for purposes of demonstrating the benefits of working with the EW team and not for the purpose of soliciting investors. Portfolio company executives receive/received a salary and economics from the portfolio company. No executives were paid for their testimonial or endorsement. There is a conflict of interest in these unpaid testimonials and endorsements in that all speakers stand to benefit from EW’s success and they work/worked for an EW portfolio company.